AGE BIAS IN CLINICAL TRIALS OF PARKINSON'S DISEASE TREATMENT

被引：6
|
作者：
Rajapakse, Anoja [1 ]
Rajapakse, Senaka [2 ]
Playfer, Jeremy [3 ,4 ]
机构：
[1] Sherwood Forest NHS Trust, Newark Hosp, Dept Gen Med, Newark, NJ USA
[2] Univ Colombo, Fac Med, Dept Clin Med, Colombo, Sri Lanka
[3] Royal Liverpool Hosp, Dept Geriatr Med, Liverpool L7 8XP, Merseyside, England
[4] Broadgreen Hosp, Dept Geriatr Med, Liverpool L14 3LB, Merseyside, England
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2008年 / 56卷 / 12期
关键词：
D O I：
10.1111/j.1532-5415.2008.02024.x
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：2353 / 2354
页数：2
相关论文
共 50 条
  • [21] Patterns of outcome measurement in Parkinson's disease clinical trials
    Mitchell, SL
    Harper, DW
    Lau, A
    Bhalla, R
    NEUROEPIDEMIOLOGY, 2000, 19 (02) : 100 - 108
  • [22] Parkinson's disease: From human genetics to clinical trials
    van der Brug, Marcel P.
    Singleton, Andrew
    Gasser, Thomas
    Lewis, Patrick A.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (305)
  • [23] Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease
    Arnulf, I.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S204 - S204
  • [24] Representational Disparities in the Enrollment of Parkinson's Disease Clinical Trials
    Tsai, Chia-Chen
    Tao, Brendan
    Lin, Vallen
    Lo, Jaden
    Brahmbhatt, Suhangi
    Kalo, Carmen
    Marras, Connie
    Khosa, Faisal
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [25] Status and future directions of clinical trials in Parkinson's disease
    Soderbom, Grazyna
    METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: NEURODEGENERATIVE DISEASE RESEARCH AND COMMONALITIES WITH METABOLIC DISEASES, 2020, 154 : 153 - 188
  • [26] An overview of the active clinical trials for Parkinson's disease psychosis
    Kwan, Cynthia
    Huot, Philippe
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2022, 12 (04) : 165 - 170
  • [27] Parkinson's disease: clinical manifestations and treatment
    Dawson, TM
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2000, 12 (04) : 263 - 269
  • [28] A Comprehensive Review on Repurposing the Nanocarriers for the Treatment of Parkinson's Disease: An Updated Patent and Clinical Trials
    Khan, Sara
    Haider, Md. Faheem
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2025, 24 (03) : 181 - 195
  • [29] Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned
    Hung, Albert Y.
    Schwarzschild, Michael A.
    NEUROTHERAPEUTICS, 2020, 17 (04) : 1393 - 1405
  • [30] Clinical trials participant retention in Parkinson's Disease and Huntington Disease studies
    Ede, P. K.
    Wielinski, C. L.
    MOVEMENT DISORDERS, 2015, 30 (10) : E9 - E9
12345